An expeditious four-component domino protocol for the synthesis of novel thiazolo[3,2-a]thiochromeno[4,3-d]pyrimidine derivatives as antibacterial and antibiofilm agents-Reference-Cited by-同舟云学术

An expeditious four-component domino protocol for the synthesis of novel thiazolo[3,2-a]thiochromeno[4,3-d]pyrimidine derivatives as antibacterial and antibiofilm agents

Published:2016-08 Issue:16 Volume:24 Page:3808-3817
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Suresh Lingala,Sagar Vijay Kumar P.,Poornachandra Y.,Ganesh Kumar C.,Babu Nanubolu Jagadeesh,Chandramouli G.V.P.^ORCID

Funder

CSIR

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference59 articles.

1. The global need for effective antibiotics: challenges and recent advances

2. An overview of antimicrobial resistance and its public health significance

3. Green Chemistry: Principles and Practice

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of some novel structurally diverse thiochroman derivatives as fungicides against phytopathogenic fungi;Pest Management Science;2024-09-05

2. Review on the recent development on ionic liquid promoted domino reactions in synthesis of eco-compatible and complex molecules;Journal of Ionic Liquids;2023-06

3. Evaluation of the antimicrobial activity of pyrimidine compound 3-(2-benzyloxy-2-oxoethyl)quinazoline-4(3H)-oh in relation to Klebsiella pneumoniae;Antibiotics and Chemotherapy;2023-04-29

4. Evaluation of the antimicrobial activity of a pyrimidine compound 2-methyl-3-(2-phenyl-2-oxoethyl) quinazolin-4(3H)-on against <i>Klebsiella pneumoniae</i> under <i>in vivo</i> conditions;The Siberian Journal of Clinical and Experimental Medicine;2023-04-09

5. A Combined QSAR and Molecular Docking Approach for Identifying Pyrimidine Derivatives as Penicillin Binding Protein Inhibitors;Letters in Drug Design & Discovery;2022-12